A new study suggests that there is a new drug that was developed by Kyowa Pharmaceutical that helps Parkinson’s disease patients. This drug that they are currently examining is called Istradfeylline. It works by helping nerve and brain signals bypass the damaged dopamine system in the brain which in turn leads to Parkinson’s.

The study shows that it is effective as an add on therapy to other drugs that are used to treat Parkinson’s disease. It improves the off time in about 90 percent of patients according to their investigations and tests. It is a novel drug approach to the said disease. Usually, Parkinson’s is treated with domapine but then, it wears off after some time. The drug will connect with receptors aside from dopamine to open some communications with the brain.

According to the researchers, this drug and other agents in the same class that work in other areas of the brain are an important step forward when treating patients who experience the wearing off phenomenon and side effects that are related to those of dopamine drugs.